You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

dsease remission

Showing 1 - 25 of 2,743
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rheumatoid Arthritis Trial in Hangzhou (Tofacitinib)

Recruiting
  • Rheumatoid Arthritis
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jun 9, 2021

ANCA Associated Vasculitis Trial in Beijing (Telitacicept, Placebo of Telitacicept)

Recruiting
  • ANCA Associated Vasculitis
  • Beijing, China
    Peking Union Medical College Hospital
Jul 19, 2023

Dissecting Cellular and Molecular Atlas of Rheumatoid Arthritis

Recruiting
  • Rheumatoid Arthritis
  • Tapering and/or discontinuation of treatment based on AI-guidance
  • +3 more
  • Rome, Italy
  • +3 more
Jul 20, 2023

Ulcerative Colitis Trial in Belgium (5-ASA)

Recruiting
  • Ulcerative Colitis
  • Bonheiden, Belgium
  • +15 more
Aug 11, 2023

ANCA-associated Vasculitis, Maintenance Therapy Trial in Beijing (Azathioprine, Telitacicept)

Recruiting
  • ANCA-associated Vasculitis
  • Maintenance Therapy
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jul 20, 2023

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Worldwide (procedure, other, drug)

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Biospecimen Collection
  • +4 more
  • Birmingham, Alabama
  • +170 more
Jan 30, 2023

HER2-positive Metastatic Breast Cancer, Stage IV Breast Cancer Trial in Miami (Discontinuation of Anti-HER-2 Maintenance

Recruiting
  • HER2-positive Metastatic Breast Cancer
  • Stage IV Breast Cancer
  • Discontinuation of Anti-HER-2 Maintenance Treatment
  • Miami, Florida
    University of Miami
Jul 17, 2023

Oral Azacitidine Maintenance Therapy in Korean Acute Myeloid

Not yet recruiting
  • Acute Myeloid Leukemia
  • Oral azacitidine
  • Seoul, Korea, Republic of
    Bristol-Myers Squibb YH
Oct 3, 2023

Disease Bowel, Crohn Disease, Ulcerative Colitis Trial in France (Sleep activity, Questionnaires)

Not yet recruiting
  • Disease Bowel
  • +2 more
  • Sleep activity
  • Questionnaires
  • Clermont-Ferrand, France
  • +3 more
Apr 28, 2023

Rheumatoid Arthritis Trial (Treatment target DAS28CRP-LDA, Treatment target SDAI-remission)

Not yet recruiting
  • Rheumatoid Arthritis
  • Treatment target DAS28CRP-LDA
  • Treatment target SDAI-remission
  • (no location specified)
Sep 13, 2023

IBD Trial (Mediterranean diet and Anti-inflammatory diet)

Not yet recruiting
  • Inflammatory Bowel Diseases
  • Mediterranean diet and Anti-inflammatory diet
  • (no location specified)
Jun 18, 2023

Ulcerative Colitis Trial (IV MK-7240, IV Placebo, SC MK-7240)

Not yet recruiting
  • Ulcerative Colitis
  • IV MK-7240
  • +3 more
  • (no location specified)
Sep 27, 2023

Schizophrenia Trial in Taichung (NMDAE, Placebo Cap)

Not yet recruiting
  • Schizophrenia
  • Taichung, Taiwan
    Department of Psychiatry, China Medical University Hospital
Sep 4, 2023

Steroid-Sensitive Nephrotic Syndrome Trial in Shanghai (Rituximab, Corticosteroid)

Not yet recruiting
  • Steroid-Sensitive Nephrotic Syndrome
  • Shanghai, Shanghai, China
  • +2 more
May 6, 2023

Crohn's Disease Trial in Seoul (Infliximab-Dyyb)

Not yet recruiting
  • Crohn's Disease
  • Seoul, Korea, Republic of
    Asan Medical Center
Oct 5, 2023

Depression Trial (Neurofeedback sessions)

Not yet recruiting
  • Depression
  • Neurofeedback sessions
  • (no location specified)
Oct 19, 2023

Remission of Acute Charcot-Neuroarthropathy of Foot.

Recruiting
  • Acute Charcot Neuroarthropathy
  • Total conatact cast
  • Chandigarh, India
    PGIMER
Aug 23, 2023

Non-radiographic Axial Spondyloarthritis Trial (Secukinumab, Placebo)

Not yet recruiting
  • Non-radiographic Axial Spondyloarthritis
  • (no location specified)
Nov 16, 2022

Diabetic Foot Trial in Madrid (2 weeks revision)

Not yet recruiting
  • Diabetic Foot
  • 2 weeks revision
  • Madrid, Spain
    Clínica Universitaria de Podología de la Universidad Complutense
Nov 15, 2023

Relapsed/Refractory Philadelphia Positive B-precursor ALL Trial in Worldwide (Blinatumomab)

Completed
Has Results
  • Relapsed/Refractory Philadelphia Positive B-precursor ALL
  • Duarte, California
  • +21 more
Sep 8, 2022

Psoriatic Arthritis, Withdrawal, Reduction Trial in Erlangen (Prednisolone, Sulfasalazine, Leflunomide)

Recruiting
  • Psoriatic Arthritis
  • +2 more
  • Erlangen, Bavaria, Germany
    Universitätsklinikum Erlangen
Nov 10, 2022

Prognostic Model of Rituximab in the Treatment of MN

Not yet recruiting
  • Idiopathic Membranous Nephropathy
  • (no location specified)
Dec 28, 2022

Prognostic Model of GC/CTX in the Treatment of MN

Not yet recruiting
  • Idiopathic Membranous Nephropathy
  • glucocorticoid + cytoxan
  • (no location specified)
Dec 28, 2022

Idiopathic Membranous Nephropathy Trial (glucocorticoid + tacrolimus)

Not yet recruiting
  • Idiopathic Membranous Nephropathy
  • glucocorticoid + tacrolimus
  • (no location specified)
Dec 28, 2022

Prognostic Model of TAC in the Treatment of MN

Not yet recruiting
  • Idiopathic Membranous Nephropathy
  • (no location specified)
Dec 28, 2022